TF is abnormally elevated on the surface of many types of malignant tumor cells and vascular endothelial cells, including those of lung cancer, triple-negative breast cancer (TNBC), pancreatic cancer, glioma, acute lymphoblastic leukaemia and others [11–14]. Here, TF is linked to triple-negative breast carcinoma.